Brain protection during mitral valve repair
Part of Heart & circulation clinical trials.
This study tests a special protection device used during a heart procedure (called M-TEER) that repairs a leaky mitral valve. The device is designed to catch any small debris or blood clots that might break loose during the procedure, reducing the risk of a stroke or brain injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You need to have severe mitral regurgitation, a condition where one of your heart valves doesn't close tightly and blood leaks backward
- You should be experiencing symptoms like shortness of breath or tiredness during normal activities
- Your doctor must have already decided that you can have a mitral valve clip procedure (called M-TEER), which is a minimally invasive way to fix the leaky valve
- You can't have had a stroke or certain heart procedures (like bypass surgery or stents) in the last month
- You must not have any metal implants or devices that would make an MRI (magnetic imaging test) unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter-based procedure to repair a leaking mitral valve in people who are in severe heart shock and need medication support. The goal is to reduce the valve leak and see if it helps patients stabilize and recover.
This trial tests a new device to fix a leaky mitral valve in people with moderate to severe leakage who are too high-risk for open-heart surgery. It aims to improve heart function and symptoms.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
This trial tests a device placed during open heart surgery that tightens the leaking mitral valve to reduce blood flowing backward. It may help people whose valve leak is caused by heart muscle weakness and who are already having another heart surgery.
This study tests a new catheter-based system to treat severe mitral valve leaking when open-heart surgery is considered high risk. It may help improve blood flow and symptoms by repairing the valve without open surgery, using ultrasound guidance and follow-up visits to track safety and results.
This study compares different ways of using blood thinners during procedures to fix a leaky mitral valve or close the left atrial appendage. The goal is to find the safest approach to prevent strokes and bleeding.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.